Implant-Associated P. Aeruginosa Bone And Joint Infections : Experience In A Regional Reference Center In France
NCT ID: NCT03624855
Last Updated: 2018-08-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
94 participants
OBSERVATIONAL
2018-03-01
2018-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Chronic Infections on Articular Prostheses With C. Acnes Diagnosed by Specific PCR
NCT03850548
Lyon PJI Retrospective Cohort Study
NCT04722926
Short vs. Long Antibiotic Treatment of Implant-free Osteoarticular Infections
NCT03602209
Prognostic Impact of Delta-haemolysin Production Deficiency in Staphylococcus Aureus on the Prognosis of Infected Implant Treated by DAIR
NCT03796104
Treatment of the Infections on Osteo-articular Prostheses by 6 Versus 12 Weeks of Antibiotherapy
NCT01816009
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Description of BJI due to Pseudomonas aeruginosa
patients having bone and joint infection on implant due to Pseudomonas aeruginosa
Bone or joint infection due to Pseudomonas aeruginosa
Description of bone or joint infection on implant due to Pseudomonas aeruginosa
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bone or joint infection due to Pseudomonas aeruginosa
Description of bone or joint infection on implant due to Pseudomonas aeruginosa
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eugénie MABRUT
Clinical Research Assistant
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tristan FERRY, Md,PhD
Role: PRINCIPAL_INVESTIGATOR
Hospices Civils de Lyon Hôpital de la Croix-Rousse
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospices Civils de Lyon
Lyon, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18-176
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.